SYNKAYVITE Drug Patent Profile
✉ Email this page to a colleague
When do Synkayvite patents expire, and when can generic versions of Synkayvite launch?
Synkayvite is a drug marketed by Roche and is included in one NDA.
The generic ingredient in SYNKAYVITE is menadiol sodium diphosphate. There is one drug master file entry for this compound. Additional details are available on the menadiol sodium diphosphate profile page.
Summary for SYNKAYVITE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 7 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SYNKAYVITE at DailyMed |
US Patents and Regulatory Information for SYNKAYVITE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | SYNKAYVITE | menadiol sodium diphosphate | TABLET;ORAL | 003718-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |